RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2017

Oct 4, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2017-10-04

Reporting Person: Smith Hunter C (CFO and Treasurer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$6.88	2027-08-08	Common Stock (201744)		Direct

Footnotes

F1: The stock options were granted on August 9, 2017. The stock options vest and become exercisable as to 25% of the total shares on July 31, 2018 and, thereafter, vest and become exercisable in 36 successive, equal monthly installments.